Please ensure Javascript is enabled for purposes of website accessibility

FDA-approved marijuana

Acting U.S. Attorney General Todd Blanche speaks during a press conference at the Department of Justice in Washington, D.C., U.S., April 21, 2026. REUTERS/Annabelle Gordon
Apr 23, 2026

US reclassifies certain marijuana products as a less-dangerous drug

The U.S. Department of Justice reschedules FDA-approved marijuana from Schedule I to Schedule III, easing research and industry restrictions.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.